Literature DB >> 31938240

Comparison of microsatellite status detection methods in colorectal carcinoma.

Mei-Li Chen1,2, Jie-Yu Chen3, Jing Hu1, Qian Chen4, Li-Xia Yu1, Bao-Rui Liu1, Xiao-Ping Qian1, Mi Yang1,2.   

Abstract

There are two commonly accepted methods for detecting microsatellite status. One is to detect amplified microsatellite loci by polymerase chain reaction (PCR) and the other is to detect mismatch repair gene (MMR) protein expression by immunohistochemistry (IHC). PCR detection is considered to be accurate in clinical operations while IHC is widely used due to ease of operation and lesser expense. In order to compare IHC with PCR in detecting microsatellite status in colorectal carcinoma, a total of 569 samples of colorectal carcinoma resection were collected in the Department of Pathology, Nanjing Drum Tower Hospital, between June 2014 and June 2017. In all samples, IHC and PCR was used to detect microsatellite status and the consistency of results between the two methods was compared. We found that 48 cases of microsatellite instability (MSI) were detected by PCR including 37 cases of microsatellite instability high (MSI-H), 11 cases of microsatellite instability low (MSI-L), and 521 cases of MSS. MSI accounted for 8.44% of all cases and MSI-H accounted for 6.50%. IHC results of the 569 patients showed that 69 cases were deficient mismatch repair (dMMR) and 500 cases were proficient mismatch repair (pMMR). dMMR accounted for 12.13% of all cases. Loss expression of PMS2 protein was the most common while MSH6 was rare. The coincidence rate of the two methods for detecting microsatellite states was 91.92%. IHC and the PCR method had high consistency in microsatellite status. Compared with PCR, the IHC method is more economical and more convenient for clinical operations. When the 4 repair proteins were without deficiency detected by IHC, it could be diagnosed as MSS/MSI-L and further PCR was not necessary. When any repair protein was found to be deficient, PCR detection was needed to determine whether MSI existed. Our conclusion will save a lot of time and costs in clinical work. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Immunohistochemistry (IHC); colorectal carcinoma; microsatellite instability (MSI); mismatch repair gene (MMR); polymerase chain reaction (PCR)

Year:  2018        PMID: 31938240      PMCID: PMC6958115     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

1.  KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.

Authors:  Ju-Xiang Ye; Yan Liu; Yun Qin; Hao-Hao Zhong; Wei-Ning Yi; Xue-Ying Shi
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Is microsatellite instability really a good prognostic factor of colorectal cancer?

Authors:  Ui Sup Shin; Sang Sik Cho; Sun Mi Moon; Sun Hoo Park; Sun Hee Jee; Eun-Joo Jung; Dae-Yong Hwang
Journal:  Ann Coloproctol       Date:  2014-02-28

3.  Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.

Authors:  Jian Qiu Sheng; Tsun Leung Chan; Yee Wai Chan; Ji Sheng Huang; Ji Gui Chen; Ming Zhi Zhang; Xiu Lan Guo; Hong Mu; Annie Sy Chan; Shi Rong Li; Siu Tsan Yuen; Suet Yi Leung
Journal:  Chin J Dig Dis       Date:  2006

4.  Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer.

Authors:  L Ghanipour; K Jirström; M Sundström; B Glimelius; H Birgisson
Journal:  Eur J Surg Oncol       Date:  2016-10-31       Impact factor: 4.424

5.  Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.

Authors:  Birgül Karahan; Asuman Argon; Mehmet Yıldırım; Enver Vardar
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

6.  Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel.

Authors:  Naim Abu Freha; Yaara Leibovici Weissman; Alexander Fich; Inbal Barnes Kedar; Marisa Halpern; Ignacio Sztarkier; Doron M Behar; Orly Arbib Sneh; Alex Vilkin; Hagit N Baris; Rachel Gingold; Flavio Lejbkowicz; Yaron Niv; Yael Goldberg; Zohar Levi
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

7.  Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).

Authors:  J Goldstein; B Tran; J Ensor; P Gibbs; H L Wong; S F Wong; E Vilar; J Tie; R Broaddus; S Kopetz; J Desai; M J Overman
Journal:  Ann Oncol       Date:  2014-02-27       Impact factor: 32.976

Review 8.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

9.  Immunohistochemical expression pattern of MMR protein can specifically identify patients with colorectal cancer microsatellite instability.

Authors:  Arfaoui Toumi Amira; Trabelsi Mouna; Blel Ahlem; Aloui Raoudha; Ben Hmida Majid; Hamza Amel; Zermani Rachida; Kourdaa Nadia
Journal:  Tumour Biol       Date:  2014-03-19

10.  Clinico-pathologic Parameters for Prediction of Microsatellite Instability in Colorectal Cancer.

Authors:  Sang-Bong Jung; Han-Il Lee; Hoon-Kyu Oh; Im-Hee Shin; Chang-Ho Jeon
Journal:  Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.679

View more
  6 in total

1.  Familial Lynch syndrome with early age of onset and confirmed splice site mutation in MSH2: A case report.

Authors:  Zornitsa Bogomilova Kamburova; Savelina Lubenova Popovska; Katya Stefanova Kovacheva; Krasimir Todorov Petrov; Slavena Enkova Nikolova
Journal:  Biomed Rep       Date:  2022-03-14

2.  Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry.

Authors:  Federica Zito Marino; Martina Amato; Andrea Ronchi; Iacopo Panarese; Franca Ferraraccio; Ferdinando De Vita; Giuseppe Tirino; Erika Martinelli; Teresa Troiani; Gaetano Facchini; Felice Pirozzi; Michele Perrotta; Pasquale Incoronato; Raffaele Addeo; Francesco Selvaggi; Francesco Saverio Lucido; Michele Caraglia; Giovanni Savarese; Roberto Sirica; Marika Casillo; Eva Lieto; Annamaria Auricchio; Francesca Cardella; Ludovico Docimo; Gennaro Galizia; Renato Franco
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

3.  Molecular profiling of the colon cancer in South-Eastern Romania: Results from the MERCUR study.

Authors:  Razvan Catalin Popescu; Cristina Tocia; Costel Brînzan; Georgeta Camelia Cozaru; Mariana Deacu; Andrei Dumitru; Nicoleta Leopa; Anca Florentina Mitroi; Anca Nicolau; Eugen Dumitru
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

4.  Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature.

Authors:  Marloes Swets; Cristina Graham Martinez; Shannon van Vliet; Arjan van Tilburg; Hans Gelderblom; Corrie A M Marijnen; Cornelis J H van de Velde; Iris D Nagtegaal
Journal:  Histopathology       Date:  2022-07-14       Impact factor: 7.778

5.  Prognosis-related genes participate in immunotherapy of renal clear cell carcinoma possibly by targeting dendritic cells.

Authors:  Guodong Fang; Xudan Wang
Journal:  Front Cell Dev Biol       Date:  2022-09-29

6.  Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment.

Authors:  Zhenghang Wang; Xiaochen Zhao; Chan Gao; Jifang Gong; Xicheng Wang; Jing Gao; Zhongwu Li; Jie Wang; Bo Yang; Lei Wang; Bei Zhang; Yifan Zhou; Dalei Wang; Xiaofang Li; Yuezong Bai; Jian Li; Lin Shen
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.